| Literature DB >> 32659766 |
Dror Dicker1,2, Silvia Bettini3,4, Nathalie Farpour-Lambert3,5, Gema Frühbeck3,6, Rachel Golan3,7, Gijs Goossens3,8, Jason Halford3,9, Grace O'Malley3,10, Dana Mullerova3,11, Ximena Ramos Salas3, Maria N Hassapiou12, Jørn Sagen3,13, Euan Woodward3, Volkan Yumuk3,14, Luca Busetto3,4.
Abstract
The World Health Organization declared COVID-19, the infectious disease caused by the coronavirus SARS-CoV-2, a pandemic on March 12, 2020. COVID-19 is causing massive health problems and economic suffering around the world. The European Association for the Study of Obesity (EASO) promptly recognised the impact that the outbreak could have on people with obesity. On one side, emerging data suggest that obesity represents a risk factor for a more serious and complicated course of COVID-19 in adults. On the other side, the health emergency caused by the outbreak diverts attention from the prevention and care of non-communicable chronic diseases to communicable diseases. This might be particularly true for obesity, a chronic and relapsing disease frequently neglected and linked to significant bias and stigmatization. The Obesity Management Task Force (OMTF) of EASO contributes in this paper to highlighting the key aspects of these two sides of the coin and suggests some specific actions.Entities:
Keywords: Barrier to treatment; COVID-19; Obesity; Pandemic; SARS-CoV-2
Mesh：
Year: 2020 PMID： 32659766 PMCID： PMC7841065 DOI： 10.1159/000510005
Source DB: PubMed Journal: Obes Facts ISSN： 1662-4025 Impact factor: 3.942